Mark Minden

39PUBLICATIONS

296CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsHaematologyCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipidsMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jun 20, 2026

Aberrant splicing of MBD1 reshapes the epigenome to drive convergent myeloerythroid defects in MDS.

|May 05, 2026

ATP2B1 expression identifies human hematopoietic stem cells with superior repopulation and self-renewal.

|Apr 20, 2026

IFNγ Drives Long-Term Bone Marrow Niche Dysfunction Following Doxorubicin-Based Chemotherapy.

|Feb 26, 2026

Targeting ABCD1 inhibits peroxisomal fatty acid oxidation to selectively eliminate acute myeloid leukemia cells.

Ekaterina N Parfenova, Nikolina Vrdoljak, Drake Mosca

|Feb 24, 2026

A metabolism-specific drug-repurposing screen reveals itraconazole as a potent OXPHOS inhibitor in acute myeloid leukemia.

Ekaterini Himonas, Lucie de Beauchamp, Désirée Zerbst

|Jan 02, 2026

A stem and progenitor cell-derived gene expression signature is prognostic for survival in myelofibrosis.

Jessie J F Medeiros, Andy G X Zeng, Suraj Bansal

Pageof 7

Frequent Collaborators

John E Dick

Sagi Abelson

Julie A Reisz

Angelo D'Alessandro

Soheil Jahangiri

Anastasia N Tikhonova

Paul A Spagnuolo

Suraj Bansal

Andrea Arruda

Aaron D Schimmer

Frequent Collaborators

John E Dick

Sagi Abelson

Julie A Reisz

Angelo D'Alessandro